Liver Cirrhosis Treatment Market 2027 by Disease Type, Drug Type, Distribution Channel and Geography | The Insight Partners

Liver Cirrhosis Treatment Market to 2027 - Global Analysis and Forecasts By Disease Type ( Alcoholic Cirrhosis, Atrophic Cirrhosis, Biliary Cirrhosis, Cardiac Cirrhosis, Cryptogenic Cirrhosis ); Drug Type ( Anti-Rejection Drugs/Immunosupressants, Chemotherapy Drugs, Targeted therapy, Vaccines, Anti-Viral Drugs, IImmunoglobulins, Corticosteroids ); Distribution Channel ( Hospital Pharmacies, Retail Pharmacies, Online Pharmacies ) and Geography

Report Code: TIPRE00006978 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
MARKET INTRODUCTION

Liver cirrhosis is late stage fibrosis of the liver, which is caused due to liver diseases like hepatitis and chronic alcoholism. Whenever the liver is injured, scar tissues are formed. As the liver cirrhosis progresses, more and more scar tissues are formed, which makes the functioning of the liver difficult. Liver cirrhosis cannot be reversed; however, early diagnosis can be treated, and further damage can be prevented.

MARKET DYNAMICS

The liver cirrhosis treatment market is anticipated to grow in the forecast, owing to the factors such as increasing prevalence of liver diseases, rising number of geriatric population and increasing R&D activities to develop innovative products. Furthermore, Availability of generic and bio-similar drugs and sedentary lifestyle such as increasing consumption of alcohol, unhealthy diets is likely to pose growth opportunities for the liver cirrhosis treatment market to grow.

MARKET SCOPE

The "Global Liver cirrhosis treatment market Analysis to 2027" is a specialized and in-depth study of the Pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of liver cirrhosis treatment market with detailed market segmentation by disease type, drug type, distribution channel and geography. The global liver cirrhosis treatment market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading liver cirrhosis treatment market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The global liver cirrhosis treatment market is segmented on the basis of disease type, drug type, and distribution channel. Based on disease type, the market is segmented into alcoholic cirrhosis, atrophic cirrhosis, biliary cirrhosis, cardiac cirrhosis, and cryptogenic cirrhosis. The drug type segment is further divided into anti-rejection drugs/immunosupressants, chemotherapy drugs, targeted therapy, vaccines, anti-viral drugs, immunoglobulins, corticosteroids. Based on distribution channel the market is segmented into hospital pharmacies, retail pharmacies, and online pharmacies.

REGIONAL FRAMEWORK


The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global liver cirrhosis treatment market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The liver cirrhosis treatment market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting liver cirrhosis treatment market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the liver cirrhosis treatment market in these regions.

MARKET PLAYERS


The reports cover key developments in the liver cirrhosis treatment market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from liver cirrhosis treatment market are anticipated to lucrative growth opportunities in the future with the rising demand for liver cirrhosis treatment market in the global market. Below mentioned is the list of few companies engaged in the liver cirrhosis treatment market.

The report also includes the profiles of liver cirrhosis treatment market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
  •  Gilead Science Inc.
  •  Bayer AG
  •  AstraZeneca
  •  GlaxoSmithKline plc
  •  Merck & Co. Inc
  •  Sanofi
  •  Pfizer Inc.
  •  F. Hoffmann-La Roche AG
  •  Novartis AG
  •  Johnson &Johnson Private Limited
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Liver Cirrhosis Treatment Market - By Disease Type
1.3.2 Liver Cirrhosis Treatment Market - By Drug Type
1.3.3 Liver Cirrhosis Treatment Market - By Distribution Channel
1.3.4 Liver Cirrhosis Treatment Market - By Region
1.3.4.1 By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. LIVER CIRRHOSIS TREATMENT MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. LIVER CIRRHOSIS TREATMENT MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. LIVER CIRRHOSIS TREATMENT MARKET - GLOBAL MARKET ANALYSIS
6.1. LIVER CIRRHOSIS TREATMENT - GLOBAL MARKET OVERVIEW
6.2. LIVER CIRRHOSIS TREATMENT - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. LIVER CIRRHOSIS TREATMENT MARKET - REVENUE AND FORECASTS TO 2027 - DISEASE TYPE
7.1. OVERVIEW
7.2. DISEASE TYPE MARKET FORECASTS AND ANALYSIS
7.3. ALCOHOLIC CIRRHOSIS
7.3.1. Overview
7.3.2. Alcoholic Cirrhosis Market Forecast and Analysis
7.4. ATROPHIC CIRRHOSIS
7.4.1. Overview
7.4.2. Atrophic Cirrhosis Market Forecast and Analysis
7.5. BILIARY CIRRHOSIS
7.5.1. Overview
7.5.2. Biliary Cirrhosis Market Forecast and Analysis
7.6. CARDIAC CIRRHOSIS
7.6.1. Overview
7.6.2. Cardiac Cirrhosis Market Forecast and Analysis
7.7. CRYPTOGENIC CIRRHOSIS
7.7.1. Overview
7.7.2. Cryptogenic Cirrhosis Market Forecast and Analysis
8. LIVER CIRRHOSIS TREATMENT MARKET - REVENUE AND FORECASTS TO 2027 - DRUG TYPE
8.1. OVERVIEW
8.2. DRUG TYPE MARKET FORECASTS AND ANALYSIS
8.3. ANTI-REJECTION DRUGS/IMMUNOSUPRESSANTS
8.3.1. Overview
8.3.2. Anti-Rejection Drugs/Immunosupressants Market Forecast and Analysis
8.4. CHEMOTHERAPY DRUGS
8.4.1. Overview
8.4.2. Chemotherapy Drugs Market Forecast and Analysis
8.5. TARGETED THERAPY
8.5.1. Overview
8.5.2. Targeted therapy Market Forecast and Analysis
8.6. VACCINES
8.6.1. Overview
8.6.2. Vaccines Market Forecast and Analysis
8.7. ANTI-VIRAL DRUGS
8.7.1. Overview
8.7.2. Anti-Viral Drugs Market Forecast and Analysis
8.8. IIMMUNOGLOBULINS
8.8.1. Overview
8.8.2. IImmunoglobulins Market Forecast and Analysis
8.9. CORTICOSTEROIDS
8.9.1. Overview
8.9.2. Corticosteroids Market Forecast and Analysis
9. LIVER CIRRHOSIS TREATMENT MARKET - REVENUE AND FORECASTS TO 2027 - DISTRIBUTION CHANNEL
9.1. OVERVIEW
9.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
9.3. HOSPITAL PHARMACIES
9.3.1. Overview
9.3.2. Hospital Pharmacies Market Forecast and Analysis
9.4. RETAIL PHARMACIES
9.4.1. Overview
9.4.2. Retail Pharmacies Market Forecast and Analysis
9.5. ONLINE PHARMACIES
9.5.1. Overview
9.5.2. Online Pharmacies Market Forecast and Analysis
10. LIVER CIRRHOSIS TREATMENT MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Liver Cirrhosis Treatment Market Overview
10.1.2 North America Liver Cirrhosis Treatment Market Forecasts and Analysis
10.1.3 North America Liver Cirrhosis Treatment Market Forecasts and Analysis - By Disease Type
10.1.4 North America Liver Cirrhosis Treatment Market Forecasts and Analysis - By Drug Type
10.1.5 North America Liver Cirrhosis Treatment Market Forecasts and Analysis - By Distribution Channel
10.1.6 North America Liver Cirrhosis Treatment Market Forecasts and Analysis - By Countries
10.1.6.1 United States Liver Cirrhosis Treatment Market
10.1.6.1.1 United States Liver Cirrhosis Treatment Market by Disease Type
10.1.6.1.2 United States Liver Cirrhosis Treatment Market by Drug Type
10.1.6.1.3 United States Liver Cirrhosis Treatment Market by Distribution Channel
10.1.6.2 Canada Liver Cirrhosis Treatment Market
10.1.6.2.1 Canada Liver Cirrhosis Treatment Market by Disease Type
10.1.6.2.2 Canada Liver Cirrhosis Treatment Market by Drug Type
10.1.6.2.3 Canada Liver Cirrhosis Treatment Market by Distribution Channel
10.1.6.3 Mexico Liver Cirrhosis Treatment Market
10.1.6.3.1 Mexico Liver Cirrhosis Treatment Market by Disease Type
10.1.6.3.2 Mexico Liver Cirrhosis Treatment Market by Drug Type
10.1.6.3.3 Mexico Liver Cirrhosis Treatment Market by Distribution Channel
10.2. EUROPE
10.2.1 Europe Liver Cirrhosis Treatment Market Overview
10.2.2 Europe Liver Cirrhosis Treatment Market Forecasts and Analysis
10.2.3 Europe Liver Cirrhosis Treatment Market Forecasts and Analysis - By Disease Type
10.2.4 Europe Liver Cirrhosis Treatment Market Forecasts and Analysis - By Drug Type
10.2.5 Europe Liver Cirrhosis Treatment Market Forecasts and Analysis - By Distribution Channel
10.2.6 Europe Liver Cirrhosis Treatment Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Liver Cirrhosis Treatment Market
10.2.6.1.1 Germany Liver Cirrhosis Treatment Market by Disease Type
10.2.6.1.2 Germany Liver Cirrhosis Treatment Market by Drug Type
10.2.6.1.3 Germany Liver Cirrhosis Treatment Market by Distribution Channel
10.2.6.2 France Liver Cirrhosis Treatment Market
10.2.6.2.1 France Liver Cirrhosis Treatment Market by Disease Type
10.2.6.2.2 France Liver Cirrhosis Treatment Market by Drug Type
10.2.6.2.3 France Liver Cirrhosis Treatment Market by Distribution Channel
10.2.6.3 Italy Liver Cirrhosis Treatment Market
10.2.6.3.1 Italy Liver Cirrhosis Treatment Market by Disease Type
10.2.6.3.2 Italy Liver Cirrhosis Treatment Market by Drug Type
10.2.6.3.3 Italy Liver Cirrhosis Treatment Market by Distribution Channel
10.2.6.4 Spain Liver Cirrhosis Treatment Market
10.2.6.4.1 Spain Liver Cirrhosis Treatment Market by Disease Type
10.2.6.4.2 Spain Liver Cirrhosis Treatment Market by Drug Type
10.2.6.4.3 Spain Liver Cirrhosis Treatment Market by Distribution Channel
10.2.6.5 United Kingdom Liver Cirrhosis Treatment Market
10.2.6.5.1 United Kingdom Liver Cirrhosis Treatment Market by Disease Type
10.2.6.5.2 United Kingdom Liver Cirrhosis Treatment Market by Drug Type
10.2.6.5.3 United Kingdom Liver Cirrhosis Treatment Market by Distribution Channel
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Liver Cirrhosis Treatment Market Overview
10.3.2 Asia-Pacific Liver Cirrhosis Treatment Market Forecasts and Analysis
10.3.3 Asia-Pacific Liver Cirrhosis Treatment Market Forecasts and Analysis - By Disease Type
10.3.4 Asia-Pacific Liver Cirrhosis Treatment Market Forecasts and Analysis - By Drug Type
10.3.5 Asia-Pacific Liver Cirrhosis Treatment Market Forecasts and Analysis - By Distribution Channel
10.3.6 Asia-Pacific Liver Cirrhosis Treatment Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Liver Cirrhosis Treatment Market
10.3.6.1.1 Australia Liver Cirrhosis Treatment Market by Disease Type
10.3.6.1.2 Australia Liver Cirrhosis Treatment Market by Drug Type
10.3.6.1.3 Australia Liver Cirrhosis Treatment Market by Distribution Channel
10.3.6.2 China Liver Cirrhosis Treatment Market
10.3.6.2.1 China Liver Cirrhosis Treatment Market by Disease Type
10.3.6.2.2 China Liver Cirrhosis Treatment Market by Drug Type
10.3.6.2.3 China Liver Cirrhosis Treatment Market by Distribution Channel
10.3.6.3 India Liver Cirrhosis Treatment Market
10.3.6.3.1 India Liver Cirrhosis Treatment Market by Disease Type
10.3.6.3.2 India Liver Cirrhosis Treatment Market by Drug Type
10.3.6.3.3 India Liver Cirrhosis Treatment Market by Distribution Channel
10.3.6.4 Japan Liver Cirrhosis Treatment Market
10.3.6.4.1 Japan Liver Cirrhosis Treatment Market by Disease Type
10.3.6.4.2 Japan Liver Cirrhosis Treatment Market by Drug Type
10.3.6.4.3 Japan Liver Cirrhosis Treatment Market by Distribution Channel
10.3.6.5 South Korea Liver Cirrhosis Treatment Market
10.3.6.5.1 South Korea Liver Cirrhosis Treatment Market by Disease Type
10.3.6.5.2 South Korea Liver Cirrhosis Treatment Market by Drug Type
10.3.6.5.3 South Korea Liver Cirrhosis Treatment Market by Distribution Channel
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Liver Cirrhosis Treatment Market Overview
10.4.2 Middle East and Africa Liver Cirrhosis Treatment Market Forecasts and Analysis
10.4.3 Middle East and Africa Liver Cirrhosis Treatment Market Forecasts and Analysis - By Disease Type
10.4.4 Middle East and Africa Liver Cirrhosis Treatment Market Forecasts and Analysis - By Drug Type
10.4.5 Middle East and Africa Liver Cirrhosis Treatment Market Forecasts and Analysis - By Distribution Channel
10.4.6 Middle East and Africa Liver Cirrhosis Treatment Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Liver Cirrhosis Treatment Market
10.4.6.1.1 South Africa Liver Cirrhosis Treatment Market by Disease Type
10.4.6.1.2 South Africa Liver Cirrhosis Treatment Market by Drug Type
10.4.6.1.3 South Africa Liver Cirrhosis Treatment Market by Distribution Channel
10.4.6.2 Saudi Arabia Liver Cirrhosis Treatment Market
10.4.6.2.1 Saudi Arabia Liver Cirrhosis Treatment Market by Disease Type
10.4.6.2.2 Saudi Arabia Liver Cirrhosis Treatment Market by Drug Type
10.4.6.2.3 Saudi Arabia Liver Cirrhosis Treatment Market by Distribution Channel
10.4.6.3 U.A.E Liver Cirrhosis Treatment Market
10.4.6.3.1 U.A.E Liver Cirrhosis Treatment Market by Disease Type
10.4.6.3.2 U.A.E Liver Cirrhosis Treatment Market by Drug Type
10.4.6.3.3 U.A.E Liver Cirrhosis Treatment Market by Distribution Channel
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Liver Cirrhosis Treatment Market Overview
10.5.2 South and Central America Liver Cirrhosis Treatment Market Forecasts and Analysis
10.5.3 South and Central America Liver Cirrhosis Treatment Market Forecasts and Analysis - By Disease Type
10.5.4 South and Central America Liver Cirrhosis Treatment Market Forecasts and Analysis - By Drug Type
10.5.5 South and Central America Liver Cirrhosis Treatment Market Forecasts and Analysis - By Distribution Channel
10.5.6 South and Central America Liver Cirrhosis Treatment Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Liver Cirrhosis Treatment Market
10.5.6.1.1 Brazil Liver Cirrhosis Treatment Market by Disease Type
10.5.6.1.2 Brazil Liver Cirrhosis Treatment Market by Drug Type
10.5.6.1.3 Brazil Liver Cirrhosis Treatment Market by Distribution Channel
10.5.6.2 Argentina Liver Cirrhosis Treatment Market
10.5.6.2.1 Argentina Liver Cirrhosis Treatment Market by Disease Type
10.5.6.2.2 Argentina Liver Cirrhosis Treatment Market by Drug Type
10.5.6.2.3 Argentina Liver Cirrhosis Treatment Market by Distribution Channel
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. LIVER CIRRHOSIS TREATMENT MARKET, KEY COMPANY PROFILES
12.1. GILEAD SCIENCE INC.
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. BAYER AG
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. ASTRAZENECA
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. GLAXOSMITHKLINE PLC
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. MERCK AND CO. INC
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. SANOFI
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. PFIZER INC.
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. F. HOFFMANN-LA ROCHE AG
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. NOVARTIS AG
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. JOHNSON AND JOHNSON PRIVATE LIMITED
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. Gilead Science Inc.
2. Bayer AG
3. AstraZeneca
4. GlaxoSmithKline plc
5. Merck & Co. Inc
6. Sanofi
7. Pfizer Inc.
8. F. Hoffmann-La Roche AG
9. Novartis AG
10. Johnson &Johnson Private Limited